Hit enter to search or ESC to close
IDEAYA Biosciences
  • Company
  • Science
  • Pipeline
  • Newsroom
  • Investors
  • Careers
  • Contact
  • Overview
  • News Releases
  • Events
  • Stock Information
    • Quote
    • Interactive Chart
  • Corporate Governance
    • Documents & Charters
    • Board Committees
  • Financial Information
    • Snapshot
    • SEC Filings
    • Analyst Coverage
    • Key Ratios
  • Investor Resources
    • Contact IR
    • FAQs
    • Investor Alerts
    • RSS
Investors Menu
  • Overview
  • News Releases
  • Events
  • Stock Information
    • Quote
    • Interactive Chart
  • Corporate Governance
    • Documents & Charters
    • Board Committees
  • Financial Information
    • Snapshot
    • SEC Filings
    • Analyst Coverage
    • Key Ratios
  • Investor Resources
    • Contact IR
    • FAQs
    • Investor Alerts
    • RSS

Financial Information

SnapshotSEC Filings Analyst Coverage Key Ratios

This section of the IDEAYA Biosciences InvestorRoom houses up to date financial reporting information and interactive tools to provide you with the resources you need to manipulate and understand our current financial standing. 

Please note:  All data in this section is provided by a 3rd party provider and may be delayed up to 20 minutes.  IDEAYA Biosciences assumes no responsibility for the accuracy of this data and provides it for informational purposes only.

NASDAQIDYA
1dy
1mo
6mo
1yr
5yr
Beta1.77
Shares Outstanding38.6M
Average Volume (10 days)293.3K
Qtrly Dividend (Ann. Yield)-- (--)

Per Share Data

Earnings (TTM)($1.49)
Sales (TTM)$0.83
Book Value (MRQ)$7.47
Cash Flow (TTM)($1.67)
Cash (MRQ)$6.55

Analyst Views

Current Mean RecommendationStrong Buy
Strong Buy7
 
Buy0
 
Hold0
 
Underperform0
 
Sell0
 

Recent Insider Transactions

Michael Dillon
SVP, Chief Scientific Officer
(500)
Sell
Oct 4, 2021
Michael Dillon
SVP, Chief Scientific Officer
(1,000)
Sell
Oct 4, 2021
Michael Dillon
SVP, Chief Scientific Officer
(11,184)
Sell
Sep 8, 2021
Michael Dillon
SVP, Chief Scientific Officer
(200)
Sell
Sep 8, 2021
Michael Dillon
SVP, Chief Scientific Officer
(116)
Sell
Sep 7, 2021

Recent SEC Filings

10-Q
Quarterly Financials
May 10, 2022
8-K
Company Events
May 10, 2022
SC 13G
>= 5% Acquisition
May 2, 2022
DEF 14A
Proxy Statement
Apr 26, 2022
4
Insider Buy/Sell
Apr 14, 2022
Currency in USD.
Quote data delayed by at least 15 minutes.
Earnings and Analyst data provided by Zacks.
Insiders data provided by Morningstar.

© 2022 IDEAYA Biosciences | Terms of Use | Privacy Policy

  • Company
  • Science
  • Pipeline
  • Newsroom
  • Investors
  • Careers
  • Contact